Veriteque USA announced a distribution agreement with OraSure Technologies on February 20, 2024. The agreement covered the SwabTek surface-test range, offered as a complement to OraSure's oral-fluid screening products.
The announcement described an opportunity to reach businesses, educators and third-party administrators already served by OraSure. Adding surface tests gave those buyers another type of tool for questions involving suspected substances on objects and paraphernalia.
The distinction is important in a workplace: screening residue on an item is different from collecting a biological sample from an employee. SwabTek's dry-reagent tests provide an initial indication about the material sampled. They do not establish a person's drug use or impairment. This dated announcement documents the original agreement and its intended role in bringing surface testing to more organizations.
